I agree that this site is using cookies. You can find further informations here.
X
Osselaer, Jean C.
30  results:
Search for persons X
?
1

A prospective observational cohort safety study of 5106 pla..:

Osselaer, Jean C. ; Messe, Nathalie ; Hervig, Tor...
Transfusion.  48 (2008)  6 - p. 1061-1071 , 2008
Link: https://doi.org/10.1111/..
 
?
2

Management of anticoagulation during cardiopulmonary bypass..:

Ducart, Anne R. ; Collard, Edith L. ; Osselaer, Jean C....
Journal of Cardiothoracic and Vascular Anesthesia.  11 (1997)  7 - p. 878-879 , 1997
Link: https://doi.org/10.1016/..
 
?
3

Universal adoption of pathogen inactivation of platelet com..:

Osselaer, Jean Claude ; Doyen, Chantal ; Defoin, Laurence...
Transfusion.  49 (2009)  7 - p. 1412-1422 , 2009
Link: https://doi.org/10.1111/..
 
?
4

Dix ans d'expérience d'inactivation des agents pathogènes p..:

Osselaer, J.C. ; Buser, A. ; Tissot, J.D..
Transfusion Clinique et Biologique.  21 (2014)  4-5 - p. 262 , 2014
Link: https://doi.org/10.1016/..
 
?
5

Réactions transfusionnelles sur concentré plaquettaire (CP)..:

Barelli, S. ; Canellini, G. ; Lion, N...
Transfusion Clinique et Biologique.  21 (2014)  4-5 - p. 262-263 , 2014
Link: https://doi.org/10.1016/..
 
?
6

The clinical and biological impact of new pathogen inactiva..:

Kaiser-Guignard, Julie ; Canellini, Giorgia ; Lion, Niels...
Blood Reviews.  28 (2014)  6 - p. 235-241 , 2014
Link: https://doi.org/10.1016/..
 
?
7

Transition from Cobe Spectra to Spectra Optia device for au..:

Barelli, S. ; Imobersteg, N. ; Osselaer, J.-C....
Transfusion and Apheresis Science.  50 (2014)  - p. S9 , 2014
Link: https://doi.org/10.1016/..
 
?
8

Amotosalen‐HCl‐UVA pathogen reduction does not alter postst..:

Hamzeh‐Cognasse, H. ; Laradi, S. ; Osselaer, J. C...
Vox Sanguinis.  108 (2014)  2 - p. 205-207 , 2014
Link: https://doi.org/10.1111/..
 
?
9

Assessment of the performances of AcuStar HIT and the combi..:

Minet, V. ; Bailly, N. ; Douxfils, J....
Thrombosis Research.  132 (2013)  3 - p. 352-359 , 2013
Link: https://doi.org/10.1016/..
 
?
10

Optimization of MNC collection efficiency depending on pati..:

Osselaer, J.-C. ; Vandenbossche, S. ; van Hooydonk, M....
Transfusion and Apheresis Science.  48 (2013)  2 - p. 175-176 , 2013
Link: https://doi.org/10.1016/..
 
?
11

Six ans d'expérience d'utilisation du séparateur Amicus pou..:

Defoin, L. ; van Hooydonk, M. ; Vanden Bossche, S...
Transfusion Clinique et Biologique.  20 (2013)  3 - p. 304 , 2013
Link: https://doi.org/10.1016/..
 
?
12

Épidémiologie d'alloimmunisation anti-érythrocytaire dans u..:

Corlier, C. ; Debry, C. ; Goffaux, M...
Transfusion Clinique et Biologique.  20 (2013)  3 - p. 288-289 , 2013
Link: https://doi.org/10.1016/..
 
?
13

Platelet microparticle generation assay: A valuable predict..:

Mullier, F. ; Bailly, N. ; Cornet, Y....
Immuno-analyse & Biologie Spécialisée.  27 (2012)  1 - p. 41 , 2012
Link: https://doi.org/10.1016/..
 
?
14

Biobanks of blood from donors and recipients of blood produ..:

Reesink, H. W. ; Engelfriet, C. P. ; Hyland, C. A....
Vox Sanguinis.  94 (2008)  3 - p. 242-260 , 2008
Link: https://doi.org/10.1111/..
 
?
15

An active haemovigilance programme characterizing the safet..:

Osselaer, J. C. ; Cazenave, J. P. ; Lambermont, M....
Vox Sanguinis.  94 (2008)  4 - p. 315-323 , 2008
Link: https://doi.org/10.1111/..
 
1-15